BridgeBio Pharma (BBIO) PT Raised to $91 at Goldman Sachs, Following Clinical Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. SNDK
6. HTFL
7. ADYEN:NA
8. ADYYF
9. WDAY
10. DVLT

Go back to BridgeBio Pharma (BBIO) PT Raised to $91 at Goldman Sachs, Following Clinical Update
(NASDAQ: BBIO) Delayed: 79.86 -1.35 (1.66%)
Previous Close $81.21    52 Week High $ 
Open $80.14    52 Week Low $ 
Day High $80.56    P/E N/A 
Day Low $78.60    EPS $ 
Volume 3,093,402